On: July 17, 2018 In: Press Releases

Non-Invasive Wearable Shows Promising Results in Recent Study

SAN ANTONIO, Texas — A study presented at the 2018 Society of Critical Care Medicine conference has shown that TempTraq®, a patented, wearable, Bluetooth® continuous body temperature monitor, is in agreement with Pulmonary Artery Catheters (PAC) temperature measurement, the current gold standard against which temperature comparisons are made.

The PAC is an invasive form of body temperature monitoring; however, TempTraq is a small, non-invasive patch placed on the underarm skin of patients to continuously measure axillary body temperature for up to 72 hours.

During the study at Cleveland Clinic, paired temperature measurements for both monitoring methods were taken simultaneously every two hours for an eight-hour period on 60 patients in two Intensive Care Units (ICU). In analysis, TempTraq measurements were in agreement with PAC temperature measurements (± 0.3 ° Celsius) and the precision of the two methods were not significantly different.

“The advantage of continuous temperature readings is that temperature trends can be monitored. If you can trend body temperature, there may be earlier detection of fever and an earlier initiation of therapy,” said Sandra Siedlecki, PhD, RN, CNS, Senior Nurse Scientist in Cleveland Clinic’s Office of Nursing Research and Innovation and the lead author of the study.

Although not tested in this study, through TempTraq Connect, a secure, HIPAA-compliant service supported by the Google Healthcare Cloud Platform, the device can be integrated directly into hospital central monitoring system and electronic health records (EHR) to safely and securely store patient data. Healthcare providers can then view the temperature in their system as frequently as needed and can receive real-time audible or visual temperature change alerts at the patient bedside and/or through the central nursing station.

The TempTraq system is scalable and can support a single hospital or a multi-hospital/physician group healthcare system.

Results of the study were presented at the 2018 Society of Critical Care Medicine conference in San Antonio TX, and the abstract was published in Critical Care Medicine. For more information on TempTraq, please visit www.TempTraq.com.

 

###

 

About Blue Spark Technologies, Inc.

Headquartered in Westlake, Ohio, Blue Spark Technologies, Inc. is the leader in developing thin, flexible, printed power solutions for printed electronic systems, including solutions developed utilizing their thin, flexible proprietary battery technology. Blue Spark Technologies’ latest patented innovation, TempTraq®, is the only Bluetooth®, wearable temperature monitor in the form of a soft, comfortable patch that continuously, safely and comfortably, monitors body temperature for up to 24 or 48 hours and sends alerts to Apple® or Android™ compatible mobile devices.

The company’s TempTraq Connect HIPAA-compliant service supported by Google Healthcare Cloud Platform allows parents and caregivers to monitor body temperature from anywhere. It also allows direct integration with health care provider electronic health records (EHR) systems and central nurse’s stations, providing a secure method of storing patient health care data.

TempTraq has shown proven efficacy in the most demanding environments, including two intensive care units at Cleveland Clinic, University Hospitals Seidman Cancer Center and Akron Children’s Hospital, as well as several other leading hospitals. The TempTraq system is scalable and can support a single hospital or a multi-hospital/physician group healthcare system.